publication venue for
- Alzheimer's disease polygenic risk in early- and late-onset Alzheimer's disease 2026
- 18F-FDG PET in detection of primary age-related tauopathy (PART) - Is there a role? Insights from an imaging-pathology correlation study 2025
- Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI 2025
- Discrepancies between CSF biomarker and PET determinations of elevated brain amyloid and their prognostic significance 2025
- Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts 2025
- Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition 2025
- Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies 2025
- Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET 2025
- Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS 2025
- Premenopausal bilateral oophorectomy and Alzheimer's disease imaging biomarkers later in life 2025
- Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia 2025
- Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia 2025
- Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia 2025
- Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease 2025
- The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI): Overview of consortium sites and anticipated enrollment 2025
- Advancing specificity in delirium: The delirium subtyping initiative 2024
- Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers 2024
- Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes 2024
- Lewy body dementia: Overcoming barriers and identifying solutions 2024
- Longitudinal associations of reproductive factors and exogeneous estrogens with neuroimaging biomarkers of Alzheimer's disease and cerebrovascular disease 2024
- Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies 2024
- Premenopausal bilateral oophorectomy and brain white matter brain integrity in later-life 2024
- Sex differences in brain atrophy in dementia with Lewy bodies 2024
- Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer′s Disease Study (LEADS) 2023
- Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort 2023
- Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study 2023
- Influence of amyloid and diagnostic syndrome on non-traditionalmemory scores in early-onset Alzheimer's disease 2023
- Learning slopes in early-onset Alzheimer's disease 2023
- Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort 2023
- Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection 2023
- Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease 2023
- The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (leads) Cohort 2023
- White matter changes with cerebrovascular disease and Alzheimer's disease pathologies 2023
- White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS) 2023
- The temporal onset of the core features in dementia with Lewy bodies 2022
- Education differentially contributes to cognitive reserve across racial/ethnic groups 2021
- Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration 2020
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint 2020
- Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration 2020
- Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort 2020
- Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases 2020
- Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration 2020
- Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort 2020
- Tau-positron emission tomography correlates with neuropathology findings 2020
- The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology 2020
- Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium 2020
- Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms 2019
- Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms 2019
- Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome 2019
- Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome 2019
- Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers 2019
- Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers 2019
- Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease 2019
- Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative 2019
- Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative 2019
- The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies 2018
- Understanding the impact of sex and gender in Alzheimer's disease: A call to action 2018
- An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease 2017
- Defining imaging biomarker cut points for brain aging and Alzheimer's disease 2017
- MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies 2016
- Atrial fibrillation, cognitive impairment, and neuroimaging 2016
- Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 2015
- Independent comparison of Cog State computerized testing and a standard cognitive battery with neuroimaging 2014
- Microbleeds in the logopenic variant of primary progressive aphasia 2014